Phone-Based Based Walk With Ease Program for Adults With Arthritis

Evaluating Alternative Delivery Models for Arthritis Self-management Interventions

The objective of this study is to examine the short-term (6-weeks and 6 months) and long-term (1 year) effects of a phone-based version of Walk With Ease intervention.

Study Overview

• Status: Completed
• Conditions: Arthritis; Osteoarthritis; Rheumatoid Arthritis; Lupus Erythematosus, Systemic; Fibromyalgia; Gout
• Intervention / Treatment: Behavioral: Phone-Based Walk With Ease

Detailed Description

Participants will be randomized to either start the 6-week program immediately or after one year. Our Walk with Ease by Telephone (WWE-T) program is adapted from the original 6-week community-based group walking program developed by the Arthritis Foundation for adults with arthritis. The phone-based program will include 2 phone calls each week with a trained Walk With Ease Leader for 6 weeks. Assessments will be completed before at the start of the study, 6 weeks, 6 months and at 12 months.

• Study Type: Interventional
• Enrollment (Actual): 267
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • South Carolina
    • Columbia, South Carolina, United States, 29208
      • University of South Carolina

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, fibromyalgia
• able to read and write in English
• plan to live in the Columbia, SC region for next year
• willing to be randomized to either group
• complete all baseline measure

Exclusion Criteria:

• contraindications to exercise (besides arthritis)
• are pregnant, breastfeeding, or planning to become pregnant in the next year
• have a serious cognitive impairment

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Phone-Based Walk With Ease Program; Telephone-based Walk With Ease Program adapted from the Arthritis Foundations program	Behavioral: Phone-Based Walk With Ease; 6 week phone-delivered Walk With Ease Program
Other: Delayed Phone-Based Walk With Ease Program; Telephone-Based Walk With Ease Program starting after the 1 year assessment	Behavioral: Phone-Based Walk With Ease; 6 week phone-delivered Walk With Ease Program

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Pain	Visual analog scale (0mm no/low pain to 100 mm high pain)	Baseline to 6 weeks
Change in Pain	Visual analog scale (0mm no/low pain to 100 mm high pain)	Baseline to 6 months
Change in Pain	Visual analog scale (0mm no/low pain to 100 mm high pain)	Baseline to 12 months
Change in Physical Function - Chair Stands	repetitions completed during 30 second chair stand test	Baseline to 6 weeks
Change in Physical Function - Chair Stands	repetitions completed during 30 second chair stand test	Baseline to 6 months
Change in Physical Function - Chair Stands	repetitions completed during 30 second chair stand test	Baseline to 12 months
Change in Physical Function - 6 Minute Walk	Distance walked (ft) during 6 minute walk test	Baseline to 6 weeks
Change in Physical Function - 6 Minute Walk	Distance walked (ft) during 6 minute walk test	Baseline to 6 months
Change in Physical Function - 6 Minute Walk	Distance walked (ft) during 6 minute walk test	Baseline to 12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Physical Limitations	Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability	Baseline to 6 weeks
Change in Physical Limitations	Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability	Baseline to 6 months
Change in Physical Limitations	Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability	Baseline to 12 months
Change in Physical Activity	total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors	Baseline to 6 weeks
Change in Physical Activity	total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors	Baseline to 6 months
Change in Physical Activity	total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors	Baseline to 12 months
Change in Arthritis Management Self-efficacy	Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis	Baseline to 6 weeks
Change in Arthritis Management Self-efficacy	Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis	Baseline to 6 months
Change in Arthritis Management Self-efficacy	Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis	Baseline to 12 months
Change in Blood Pressure	Diastolic blood pressure measured in mmHg	Baseline to 6 weeks
Change in Blood Pressure	Diastolic blood pressure measured in mmHg	Baseline to 6 months
Change in Blood Pressure	Diastolic blood pressure measured in mmHg	Baseline to 12 months

Collaborators and Investigators

• Sponsor: University of South Carolina
• Collaborators: Centers for Disease Control and Prevention

Publications and helpful links

Helpful Links

• Study Website

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2022
• Primary Completion (Actual): September 10, 2024
• Study Completion (Actual): September 10, 2024

Study Registration Dates

• First Submitted: March 11, 2022
• First Submitted That Met QC Criteria: March 11, 2022
• First Posted (Actual): March 21, 2022

Study Record Updates

• Last Update Posted (Actual): March 6, 2026
• Last Update Submitted That Met QC Criteria: February 13, 2026
• Last Verified: February 1, 2026

More Information

Terms related to this study

• Keywords: Arthritis; Physical activity; Intervention
• Additional Relevant MeSH Terms: Crystal Arthropathies; Musculoskeletal Diseases; Nervous System Diseases; Muscular Diseases; Neuromuscular Diseases; Joint Diseases; Rheumatic Diseases; Purine-Pyrimidine Metabolism, Inborn Errors; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Metabolic Diseases; Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Behavior; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases; Gout; Arthritis; Lupus Erythematosus, Systemic; Osteoarthritis; Fibromyalgia; Arthritis, Rheumatoid; Motor Activity; methyl hydroxyethyl cellulose
• Other Study ID Numbers: Pro00115106

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: De-identified data will be made available within 30 months of the completion of the project.
• IPD Sharing Time Frame: Data will be made available within 30 months of the completion of the project.
• IPD Sharing Access Criteria: open access
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; ICF

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No